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Abstract 
 
Endothelial dysfunction has been implicated in the pathogenesis of atherosclerosis. Salvia 
miltiorrhiza (danshen) is a traditional Chinese medicine that has been effectively used to treat 
cardiovascular disease. Cryptotanshinone (CTS), a major lipophilic compound isolated from 
S. miltiorrhiza, has been reported to possess cardioprotective effects. However, the anti-
atherogenic effects of CTS, particularly on tumor necrosis factor-α (TNF-α)-induced 
endothelial cell activation, are still unclear. This study aimed to determine the effect of CTS 
on TNF-α-induced increased endothelial permeability, monocyte adhesion, soluble 
intercellular adhesion molecule 1 (sICAM-1), soluble vascular cell adhesion molecule 1 
(sVCAM-1), monocyte chemoattractant protein 1 (MCP-1) and impaired nitric oxide 
production in human umbilical vein endothelial cells (HUVECs), all of which are early 
events occurring in atherogenesis. We showed that CTS significantly suppressed TNF-α-
induced increased endothelial permeability, monocyte adhesion, sICAM-1, sVCAM-1 and 
MCP-1, and restored nitric oxide production. These observations suggest that CTS possesses 
anti-inflammatory properties and could be a promising treatment for the prevention of 
cytokine-induced early atherogenesis.  
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